139 related articles for article (PubMed ID: 6501724)
1. Renal hemodynamic effects of vasodilation with nifedipine and hydralazine in patients with heart failure.
Elkayam U; Weber L; Campese VM; Massry SG; Rahimtoola SH
J Am Coll Cardiol; 1984 Dec; 4(6):1261-7. PubMed ID: 6501724
[TBL] [Abstract][Full Text] [Related]
2. Differences in hemodynamic response to vasodilation due to calcium channel antagonism with nifedipine and direct-acting agonism with hydralazine in chronic refractory congestive heart failure.
Elkayam U; Weber L; McKay CR; Rahimtoola SH
Am J Cardiol; 1984 Jul; 54(1):126-31. PubMed ID: 6741802
[TBL] [Abstract][Full Text] [Related]
3. Hemodynamic effects of nifedipine in congestive heart failure.
Matsumoto S; Ito T; Sada T; Takahashi M; Su KM; Ueda A; Okabe F; Sato M; Sekine I; Ito Y
Am J Cardiol; 1980 Sep; 46(3):476-80. PubMed ID: 7415993
[TBL] [Abstract][Full Text] [Related]
4. Hemodynamic effects of nifedipine versus hydralazine in primary pulmonary hypertension.
Fisher J; Borer JS; Moses JW; Goldberg HL; Niarchos AP; Whitman HH; Mermelstein M
Am J Cardiol; 1984 Sep; 54(6):646-50. PubMed ID: 6475787
[TBL] [Abstract][Full Text] [Related]
5. Acute hemodynamic effect of oral nifedipine in severe chronic congestive heart failure.
Elkayam U; Weber L; Torkan B; Berman D; Rahimtoola SH
Am J Cardiol; 1983 Nov; 52(8):1041-5. PubMed ID: 6637820
[TBL] [Abstract][Full Text] [Related]
6. Assessment of renal hemodynamic effects of nesiritide in patients with heart failure using intravascular Doppler and quantitative angiography.
Elkayam U; Akhter MW; Liu M; Hatamizadeh P; Barakat MN
JACC Cardiovasc Imaging; 2008 Nov; 1(6):765-71. PubMed ID: 19356514
[TBL] [Abstract][Full Text] [Related]
7. Nifedipine in congestive heart failure: effects on resting and exercise hemodynamics and regional blood flow.
Leier CV; Patrick TJ; Hermiller J; Pacht KD; Huss P; Magorien RD; Unverferth DV
Am Heart J; 1984 Dec; 108(6):1461-8. PubMed ID: 6507242
[TBL] [Abstract][Full Text] [Related]
8. Central and renal hemodynamic effects of a new agonist at peripheral dopamine- and beta-2 adrenoreceptors (dopexamine) in patients with heart failure.
Jamison M; Widerhorn J; Weber L; Campese V; Vasquez J; Hovanessian L; Rahimtoola SH; Elkayam U
Am Heart J; 1989 Mar; 117(3):607-14. PubMed ID: 2537556
[TBL] [Abstract][Full Text] [Related]
9. Acute hemodynamic effects of hydralazine in dogs with chronic mitral regurgitation.
Kittleson MD; Johnson LE; Oliver NB
J Am Vet Med Assoc; 1985 Aug; 187(3):258-61. PubMed ID: 4030462
[TBL] [Abstract][Full Text] [Related]
10. Spectrum of acute hemodynamic effects of nifedipine in severe congestive heart failure.
Elkayam U; Weber L; McKay C; Rahimtoola S
Am J Cardiol; 1985 Sep; 56(8):560-6. PubMed ID: 4036843
[TBL] [Abstract][Full Text] [Related]
11. Combined hemodynamic effects of nifedipine and nitroglycerin in congestive heart failure.
Kubo SH; Fox SC; Prida XE; Cody RJ
Am Heart J; 1985 Nov; 110(5):1032-4. PubMed ID: 3933315
[TBL] [Abstract][Full Text] [Related]
12. Acute hemodynamic effects of nitrendipine in chronic congestive heart failure.
Olivari MT; Levine TB; Cohn JN
J Cardiovasc Pharmacol; 1984; 6 Suppl 7():S1002-5. PubMed ID: 6085356
[TBL] [Abstract][Full Text] [Related]
13. Regional distribution of cardiac output at rest and during exercise in patients with exertional angina pectoris before and after nifedipine therapy.
Thomson A; Fletcher PJ; Harris PJ; Freedman B; Kelly DT
J Am Coll Cardiol; 1988 Apr; 11(4):837-42. PubMed ID: 3351152
[TBL] [Abstract][Full Text] [Related]
14. Effects of hydralazine on coronary blood flow and myocardial energetics in congestive heart failure.
Magorien RD; Brown GP; Unverferth DV; Nelson S; Boudoulas H; Bambach D; Leier CV
Circulation; 1982 Mar; 65(3):528-33. PubMed ID: 7055874
[TBL] [Abstract][Full Text] [Related]
15. Hemodynamic comparison of primary venous or arteriolar dilatation and the subsequent effect of furosemide in left ventricular failure after acute myocardial infarction.
Nelson GI; Silke B; Forsyth DR; Verma SP; Hussain M; Taylor SH
Am J Cardiol; 1983 Nov; 52(8):1036-40. PubMed ID: 6637819
[TBL] [Abstract][Full Text] [Related]
16. Acute electrophysiologic, hemodynamic and left ventricular effects of nifedipine and beta-blocker interactions. Maintenance of global and regional left ventricular wall motion.
Vetrovec GW; Parker VE
Am J Cardiol; 1985 May; 55(12):21E-26E. PubMed ID: 4003285
[TBL] [Abstract][Full Text] [Related]
17. Neurohumoral consequences of vasodilator therapy with hydralazine and nifedipine in severe congestive heart failure.
Elkayam U; Roth A; Hsueh W; Weber L; Freidenberger L; Rahimtoola SH
Am Heart J; 1986 Jun; 111(6):1130-8. PubMed ID: 2872793
[TBL] [Abstract][Full Text] [Related]
18. Sublingual nifedipine: acute effects in severe chronic congestive heart failure secondary to idiopathic dilated cardiomyopathy.
Miller AB; Conetta DA; Bass TA
Am J Cardiol; 1985 May; 55(11):1359-62. PubMed ID: 3993570
[TBL] [Abstract][Full Text] [Related]
19. Favorable effects of hydralazine on the hemodynamic response to isometric exercise in chronic severe aortic regurgitation.
Elkayam U; McKay CR; Weber L; Eisenberg D; Rahimtoola SH
Am J Cardiol; 1984 Jun; 53(11):1603-7. PubMed ID: 6731306
[TBL] [Abstract][Full Text] [Related]
20. A comparison of the chronic effects of oral xamoterol and enalapril on blood pressure and renal function in mild to moderate heart failure.
Jamieson MJ; Webster J; Fowler G; Rawles J; Smith FW; Petrie JC
Br J Clin Pharmacol; 1991 Mar; 31(3):305-12. PubMed ID: 1675867
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
